Diabetes and ADHD medications in Alzheimer's trial

A UK clinical trial has been launched to test existing drugs—metformin and atomoxetine—for Alzheimer's disease, aiming to reduce symptoms and slow neurodegeneration. The multi-arm, multi-stage study involves 1,200 participants across more than 30 sites, with results expected by 2030. The trial seeks to accelerate treatment development using innovative testing methods initially applied in cancer research.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل